BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28277487)

  • 21. Accessing antiretroviral therapy following release from prison.
    Baillargeon J; Giordano TP; Rich JD; Wu ZH; Wells K; Pollock BH; Paar DP
    JAMA; 2009 Feb; 301(8):848-57. PubMed ID: 19244192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
    Sculier D; Wandeler G; Yerly S; Marinosci A; Stoeckle M; Bernasconi E; Braun DL; Vernazza P; Cavassini M; Buzzi M; Metzner KJ; Decosterd LA; Günthard HF; Schmid P; Limacher A; Egger M; Calmy A;
    PLoS Med; 2020 Nov; 17(11):e1003421. PubMed ID: 33170863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
    Alsan M; Beshears J; Armstrong WS; Choi JJ; Madrian BC; Nguyen MLT; Del Rio C; Laibson D; Marconi VC
    AIDS; 2017 Jul; 31(12):1765-1769. PubMed ID: 28514277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons.
    Culbert GJ
    Int J Prison Health; 2014; 10(2):94-110. PubMed ID: 25764073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of reincarceration and disease progression among released HIV-infected inmates.
    Baillargeon J; Giordano TP; Harzke AJ; Spaulding AC; Wu ZH; Grady JJ; Baillargeon G; Paar DP
    AIDS Patient Care STDS; 2010 Jun; 24(6):389-94. PubMed ID: 20565323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
    Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
    Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomized Controlled Trial of a Text Messaging Intervention to Promote Virologic Suppression and Retention in Care in an Urban Safety-Net Human Immunodeficiency Virus Clinic: The Connect4Care Trial.
    Christopoulos KA; Riley ED; Carrico AW; Tulsky J; Moskowitz JT; Dilworth S; Coffin LS; Wilson L; Peretz JJ; Hilton JF
    Clin Infect Dis; 2018 Aug; 67(5):751-759. PubMed ID: 29474546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial.
    Gross R; Ritz J; Hughes MD; Salata R; Mugyenyi P; Hogg E; Wieclaw L; Godfrey C; Wallis CL; Mellors JW; Mudhune VO; Badal-Faesen S; Grinsztejn B; Collier AC
    Lancet Digit Health; 2019 May; 1(1):e26-e34. PubMed ID: 31528850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-infected prison inmates: depression and implications for release back to communities.
    Scheyett A; Parker S; Golin C; White B; Davis CP; Wohl D
    AIDS Behav; 2010 Apr; 14(2):300-7. PubMed ID: 18709452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.
    Saber-Tehrani AS; Springer SA; Qiu J; Herme M; Wickersham J; Altice FL
    Contemp Clin Trials; 2012 Mar; 33(2):436-44. PubMed ID: 22101218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Provider perspectives regarding the health care needs of a key population: HIV-infected prisoners after incarceration.
    Sidibe T; Golin C; Turner K; Fray N; Fogel C; Flynn P; Gould M; Knight K; Wohl D
    J Assoc Nurses AIDS Care; 2015; 26(5):556-69. PubMed ID: 26279385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention in HIV care during the 3 years following release from incarceration: A cohort study.
    Loeliger KB; Meyer JP; Desai MM; Ciarleglio MM; Gallagher C; Altice FL
    PLoS Med; 2018 Oct; 15(10):e1002667. PubMed ID: 30300351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India.
    Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V;
    BMJ; 2014 Oct; 349():g5978. PubMed ID: 25742320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Namibian prisoners describe barriers to HIV antiretroviral therapy adherence.
    Shalihu N; Pretorius L; van Dyk A; Vander Stoep A; Hagopian A
    AIDS Care; 2014; 26(8):968-75. PubMed ID: 24499371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial.
    Ekwunife OI; Anetoh MU; Kalu SO; Ele PU; Eleje GU
    Trials; 2018 Dec; 19(1):710. PubMed ID: 30594223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.
    Hanna DB; Felsen UR; Ginsberg MS; Zingman BS; Beil RS; Futterman DC; Strickler HD; Anastos K
    AIDS Res Hum Retroviruses; 2016; 32(10-11):955-963. PubMed ID: 26892622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV outcomes at a Canadian remand centre.
    Subramanian Y; Khan MN; Berger S; Foisy M; Singh A; Woods D; Pyne D; Ahmed R
    Int J Prison Health; 2016 Sep; 12(3):145-56. PubMed ID: 27548017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enrollment in outpatient care among newly released prison inmates with HIV infection.
    Baillargeon JG; Giordano TP; Harzke AJ; Baillargeon G; Rich JD; Paar DP
    Public Health Rep; 2010; 125 Suppl 1(Suppl 1):64-71. PubMed ID: 20408389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the Effect of Recent Incarceration in Prison on HIV Care Retention and Viral Suppression in Two States.
    Costa M; Montague BT; Solomon L; Sammartino C; Gutman R; Zibman C; Rosen D; Rich JD
    J Urban Health; 2018 Aug; 95(4):499-507. PubMed ID: 29717402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.